Sanofi, GSK, CSL tapped to expand US bird flu vaccine supply
GSK, Sanofi and CSL Ltd have secured $72 million from the U.S. government to ramp up production of bird flu vaccines, a ...
EU regulator reviews anti-baldness drugs over concerns of suicidal thoughts
The European drugs regulator said on Friday it was reviewing anti hair-loss drugs, including Organon's Propecia and its ...
US to double emergency bird flu vaccines as more people, herds become infected
Federal officials plan to double the stockpile of emergency bird flu vaccines as they identify more people infected with the ...
The US Is Loading Up on Bird Flu Vaccine
As more farm workers get sick with avian influenza, the US federal government is putting $72 million toward strengthening its ...
The American Journal of Managed Care3h
Adult RSV Hospitalizations: Clinical Characteristics, Risk Factors for Severe Outcomes
A new study highlights risk factors for hospitalization and severe illness among adults with respiratory syncytial virus (RSV ...
ENDPOINTS NEWS3h
BAR­DA doles out $72M to Sanofi, GSK and CSL for bird flu vac­cine sup­ply
The Center for Biomedical Advanced Research and Development Authority (BARDA) is giving $72 million to three drugmakers to ...
GSK, Sanofi, And CSL Secure US Government Fund To Boost Bird Flu Vaccine Production: Report
The U.S. government has granted $72 million to European pharma giants GSK Plc (NYSE:GSK), Sanofi SA (NASDAQ:SNY) and ...
US provides $72M to vaccine manufacturers to advance bird flu shot preparedness
There are currently no recommendations for anyone to be vaccinated against bird flu and federal health officials note this is ...
FiercePharma4h
GSK, Sanofi, CSL nab $72M in BARDA funding to boost bird flu vaccine supply
CSL Seqirus, Sanofi and GSK have collectively secured $72 million in funding from the U.S. health department to boost the ...
GSK, Sanofi, CSL said to win $72M U.S. bird flu vaccine contract (update)
Sanofi (SNY), and CSL (CSLLY) win $72M U.S. contract to expand bird flu vaccine production amid fears of human transmission.
EU regulators reviewing safety of finasteride, dutasteride
EU regulators are considering withdrawing market authorizations for two hair loss and enlarged prostate treatments over ...
GSK falls Friday, underperforms market
GSK PLC GSK shares inched down 0.07% to £14.60 Friday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE 100 Index UKX falling 0.02% to 8,280.63. Supported ...